ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1578

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats Is Crucially Dependent on the IL-23 Axis

Melissa van Tok1,2, Songqing Na3, Joel Taurog4, Dominique Baeten2,5 and Leonie van Duivenvoorde1,2, 1Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Clinical Immunology and Rheumatology/Experimental immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Eli Lilly and Company, Indianapolis, IN, 4Dept Int Med-Rheum Dis Div, University of Texas Southwestern Medical Center, Dallas, TX, 5Clinical Immunology and Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Animal models, IL-23, spondylarthritis and spondylarthropathy

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 6, 2017

Session Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: IL-17A is a central driver of spondyloarthritis (SpA) pathology. IL-17A production was originally proposed to be IL-23 dependent. Emerging preclinical and clinical evidence from SpA-related diseases such as Crohn’s disease suggest, however, that IL-17A and IL-23 have a partially overlapping but distinct biology. We aimed to assess to what extend IL-17A is dependent on IL-23 in SpA by selectively targeting the IL-23R in HLA-B27/Huβ2m transgenic rat model of SpA, which we showed previously to be IL-17A-dependent.

Methods: HLA-B27/Huβ2m tg rats were immunized with low dose heat-inactivated M. tuberculosis to induce experimental SpA. Rats were treated with anti-mouse/rat chimeric IL-23R antibody or vehicle in a prophylactic (treatment initiation before onset of symptoms) or therapeutic (treatment initiation after onset of clinical symptoms) experiment. Spondylitis and arthritis were clinically scored, hind limb swelling was measured. Ex vivo cytokine expression was measured in lymph nodes and spleen. Serum samples were analyzed for anti-IL23R exposure.

Results: During prophylactic treatment, 58% and 67% of the rats in the control group developed spondylitis and arthritis, respectively. The average arthritis score at the end of the study was 3.9±1.1 and the average hind paw swelling was 0.35±0.09 cm3. Prophylactic treatment completely protected against the development of spondylitis and arthritis (figure 1). In the therapeutic treatment strategy, however, anti-IL23R treatment failed to reduce incidence or decrease the severity of experimental SpA (figure 1). The differential effect of IL-23R targeting in the initiation phase versus established disease could not be explained by pharmacokinetic differences, serum analyses revealed similar exposure levels. Mechanistically, the expression of downstream effector cytokines such as IL-17A (p<0.05) and IL-22 (p<0.01) was reduced in the popliteal lymph nodes of rats treated prophylactically with anti-IL23R versus controls, with a similar trend in spleen. Accordingly, IL-17A production upon ex vivo re-stimulation was reduced in samples from prophylactically treated rats. In contrast, similar popliteal lymph node expression data in samples from the therapeutic experiment indicate no difference in IL-17A and IL-22 expression in the anti-IL23R treated rats compared to controls.

Conclusion: IL-17A expression and production is dependent on the IL-23 axis in the initiation phase of experimental SpA but not in established disease. Accordingly, targeting of this axis with an anti-IL23R antibody completely prevented the onset of arthritis and spondylitis in HLA-B27/Huβ2m transgenic rats, but failed to reduce axial and peripheral joint inflammation in established disease. The cellular origin of IL-23-independent IL-17A production and the relevance to human SpA remains to be investigated.


Disclosure: M. van Tok, None; S. Na, Eli Lilly and Company, 1,Eli Lilly and Company, 3; J. Taurog, Abbvie; Anges; Inc; Celgene, 5; D. Baeten, UCB, 3; L. van Duivenvoorde, None.

To cite this abstract in AMA style:

van Tok M, Na S, Taurog J, Baeten D, van Duivenvoorde L. The Initiation, but Not the Persistence, of Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats Is Crucially Dependent on the IL-23 Axis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-initiation-but-not-the-persistence-of-experimental-spondyloarthritis-in-hla-b27hu%ce%b22m-transgenic-rats-is-crucially-dependent-on-the-il-23-axis/. Accessed January 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-initiation-but-not-the-persistence-of-experimental-spondyloarthritis-in-hla-b27hu%ce%b22m-transgenic-rats-is-crucially-dependent-on-the-il-23-axis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.